Eschewing An Ipo (for Now), Sirnaomics Nabs A Rare Series E Worth $105M For Next-gen Rna Work | Fiercebiotech

by fiercebiotech.com posted 1month ago 11 views
Eschewing an IPO (for now), Sirnaomics nabs a rare series E worth $105M for next-gen RNA work badams Fri, 07/02/2021 - 09:52.

In this article

No tags related to this article.